An early adopter of the Innovative Licensing and Access Pathway (ILAP), Niche Science & Technology Ltd was the first CRO to submit a successful ILAP application.
We have the experience and understanding of the ILAP pathway to guide you in your submissions to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
Niche supported ReCode Therapeutics in launching their first UK patient study, delivering end-to-end clinical and...
Niche partnered with Erytech Pharma to rescue and rewrite substandard clinical study reports, delivering a high-quality...
Niche provided DemeRx with end-to-end support to launch a pioneering ibogaine addiction trial, covering site...
Dummy text of the printing and typesetting industry. Lorem Ipsum
Telling a story is essential to any presentation and our team integrates technical artistic ability with a comprehensive understanding of medicine and science.
Clinical trials require the production and maintenance of a wide range of essential documents to ensure that the trial is conducted in a rigorous and ethical manner.
We tailor our services to fit your needs based on your scope of funding, organisation and the level of support you require. Our team can support all your writing needs.
As scientists we are trained to be impersonal. From our first research proposal to our hundredth journal article, the.
On the order to split the MMR vaccine into three shots, and 25 years of evidence from over 23 million children showing.
For many of us, ResearchGate has become something like a ‘LinkedIn for scientists.’
Get our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
